Stocks Moving From Alpha-Rich Ideas
Thursday, EnhydrisPECorp said the pending review Vanda's key drug offered a short opportunity whether the drug wins approval or not. The stock is -20.3% since. Read article »
On August 27, Mike Arnold uncovered Steinhoff International Holdings' 36% discount to NAV despite a robust, well-diversified operating model and suggested going long. The stock is +38.4% to date. Read article »
Breaking Alpha-Rich Ideas (for Pro Subscribers) Learn more »
An Interesting Turnaround Is Happening At Cincinnati Bell by Mike Arnold
Keep Calm And Buy Craft Brew Alliance by Shaun Currie, CFA
Multi-Bagger Potential As iCAD Nears A Pivotal Inflection Point by Inflection Point Investing LLC
Oracle: 40% Upside And More For Patient Investors by Eliot Murray
Long Ideas
Irrational Sell-Off After Crede Sale Leaves Navidea Biopharmaceuticals Very Undervalued by Basileus
Every Investor Should Own Shale Oil Stocks by Atticvs Research
VirnetX: Short Term Alpha, Long Term Investment by Tom Shaughnessy
Goldman Sachs: Buying Now And Selling At 2 Times Book Value Down The Road by Achilles Research
Great Eagle: A Bargain At Half Its SOTP Valuation by Nigel Stevenson, CFA
ChinaCache: China Internet On The Cheap by Stone Fox Capital
Steel Dynamics - Your 'Must Have' Steel Play by Price Point
eBay's Wonderful Businesses Now Available At A Fair Price by Illuminati Investments
Rio Tinto - Can This Iron Ore Play Continue To Outperform? by Price Point
Coldwater Creek Throws The Kitchen Sink At Investors: Lessons For Trading At The Edge Of Bankruptcy by Dr. Duru
Nokia Will Test $8 Per Share This Year by Adrian McCarroll
NQ Mobile Joins Web Elite With Bond Offer by Doug Young
3M: Will Organic Growth Drive This Undervalued Giant? by Jeff Williams
Micron Technology: Can It Double Once More? by Achilles Research
Handy & Harman: Where Untold Stories Could Hold The Midas Touch by AlphaStreetResearch
pSivida: Thoughts In The Aftermath Of The Complete Response Letter On Iluvien by Smith On Stocks
The Tragedy Of AMD by Ashraf Eassa
Cyrusone: Illusions Of Value by Paulo Santos
Is Boise Cascade A Potential Buy At A Current Price Level? by Investing Insight
Marin Software: Getting Ready For Prime Time by Stone Fox Capital
Northwest Natural Gas: Near 5 Year Low, Healthy Dividend And Catalysts Make Utility Noteworthy by ValueArtifex
New Gold: The Hidden Genius Behind The Rainy River Acquisition by Ben Kramer-Miller
Shhhh....Broadsoft And Google Alliance Announced by Josh Burwick
Skechers 3rd Quarter Earnings Preview by Tansy Trading
Multimedia Games Is An Attractive Provider Of 'Picks And Shovels' To The Growing Casino Industry by John Leonard
Apple's Business Plan: What iPhone 5C/5S Tells Us by Quoth the Raven
J.C. Penney: A Strong Buy For Contrarian Investors With Outsized Return Potential by Achilles Research
Short Ideas
American Residential Shares' Unlocking Event Provides Shorting Play by Don Dion
Silver Wheaton Remains Overvalued Despite Stock Price Dip by Valuentum
Cheap Or Doomed: Weight Watchers Vs. Apps by YCharts
Intuitive Surgical - Don't Hesitate To Short by Zachary Schenk
The Demand Just Isn't There For Demand Media by Marshall Hargrave
SkyWest Is Flying Too High by Marshall Hargrave
Quick Picks & Lists
Goldman Sachs - Profits Remain Firm As Compensation Is Cut Aggressively by The Value Investor
Ford Once Again Leads The Pack With September Sales by Valuentum
Sub-Prime Loan Stocks: Liquidity Concerns Return by YCharts
Tripling Your Money: The Long And Short Of It by Mark Gomes
AT&T Heads List Of Barron's Picks This Week by Bret Jensen
IPO Analysis
We Cannot See Buying The Aerie Pharmaceuticals IPO by Don Dion
What Will Twitter's Q4 Revenue Look Like? by Leigh Drogen
Goldman Should Take The Endurance IPO Up To The Clouds by Don Dion
Why are you receiving this? You subscribed to Investing Ideas at Seeking Alpha.
Unsubscribe from this email or manage all your Seeking Alpha email choices here.
To ensure you receive these emails in the future, please add account@seekingalpha.com to your address book, contacts or list of safe senders.
Sent by Seeking Alpha, 345 7th Ave. Suite 1400 New York, NY 10001
No hay comentarios:
Publicar un comentario